The Alliance will continue to work on balancing all the elements necessary to ensure sustainable and healthy market dynamics for vaccines and immunisation-related products, focusing on reliable, consistent and affordable supply as an overarching objective.
Gavi will use its market shaping capabilities to drive innovation in vaccine-related products and in vaccine technologies with value-added enhancements.
More broadly, Gavi will continue to invest in innovation as a core part of its model. Building on its experience so far, a more purposeful approach will be taken to promote transformational innovations across immunisation products, services and practices to help deliver on Gavi’s equity ambition.